- About the Center
- Patient Care
- Community Outreach
- Academic Programs
- News & Media
According to the National Cancer Institute, it is estimated that 22,240 women will be diagnosed with and 14,030 women will die of ovarian cancer in 2013.
The UACC's multispecialty approach and specialized expertise in the field places it at the forefront of ovarian cancer research.
"We have a lot of cutting-edge things going on here that aren't necessarily present in other treatment facilities, and that is thanks in large part to our team approach and our reputation for pushing the envelope," said Director of Women's Cancers Setsuko K. Chambers, MD. "We don't just have a group of good doctors here. We have a team of internationally known specialists who are discovering novel treatments and understandings of ovarian cancer, both from the biolgocial perspective and from potentially live-saving surgical techniques."
The UACC's team of board-certified specialists can take care of all aspects of a patient's treatment, from personalized medical therapy, to pathology, to surgical intervention and radiation oncology.
The groundbreaking intraperitoneal chemotherapy procedure, where chemotherapy is given directly into the abdomen and pelvis through a thin tube to destroy or control cancer cells, was developed by former UACC Director David S. Alberts, MD.
Additionally, patients at the UACC have access to multiple active clinical trials and are encouraged to ask their primary care physician if they are eligible for one of these cutting-edge treatments.
Dr. Chambers explains that the key to defeating ovarian cancer continues to lie in early detection.
"We urge patients to see us as soon as possible if they have received an ovarian cancer diagnosis," Dr. Chambers said. "The earlier you catch it, the more likely the patient is to survive. Treatments are less compliated. The course is less rocky. The side effects are less detrimental. Simply put, the whole process is improved. We specialize in early-detection processes in order to give our patients the best possible treatment."
To schedule an appointment with the UACC's ovarian cancer team, please call (520) 626-9285.
-Sept. 16, 2013